China Biotechs, CDMOs Embrace Uncertain Future, New Options Amid WuXi Woes

 
• By Brian Yang

The shockwave of WuXi's withdrawal from BIO is ripping through the Chinese contract services sector. While some remain hopeful, others are preparing Plan B.

Flags of China and USA fly against blue sky
China CDMOs face uncertain future amid WuXi Apptec woes • Source: Shutterstock

More from China

More from Focus On Asia